The role of macrolides in Streptococcus pyogenes pharyngitis

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 5, 1997, Pages 562-565

  Schito, G C ^a   Pesce, A ^a   Marchese, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; MACROLIDE;

ANTIBIOTIC RESISTANCE; EDITORIAL; HUMAN; ITALY; PHARYNGITIS; PRESCRIPTION; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; HUMANS; MACROLIDES; PHARYNGITIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0030925843     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.5.562     Document Type: Editorial

References (34)

1. Örtqvist, Å. (1995). Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspective. Journal of Antimicrobial Chemotherapy 35, 205-12.
2. Marchese, A., Debbia, E. A., Arvigo, A., Pesce, A. & Schito, G. C. (1995). Susceptibility of Streptococcus pneumoniae strains isolated in Italy to penicillin and ten other antibiotics. Journal of Antimicrobial Chemotherapy 36, 833-7.
3. Goldstein, F. W., Acar, J. F. and The Alexander Project Collaborative Group (1996). Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 Western Europe and USA collaborative surveillance study. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 71-84.
4. Doern, G. V. and The Alexander Project Collaborative Group (1996). Antimicrobial resistance among lower tract isolates of Haemophilus influenzae: results of a 1992-93 Western Europe and USA collaborative surveillance study. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 59-69.
5. Berk, S. L., Kalbfleisch, J. H. and The Alexander Project Collaborative Group (1996). Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in Western Europe and in the USA. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 85-96.
6. Scopetti, F., Pataracchia, M., Pacifico, L., Ranucci, A., Morini, C., Cherchi, G. et al. (1995). A multicenter study on antimicrobial susceptibility and typing of group A streptococci (gas) from cases of pharyngo-tonsillitis and scarlet fever. Microecology and Therapy 25, 348-55.
7. Millesimo, M. & Savoia, D. (1995). Group A streptococci: evaluation of in vitro resistance to two macrolides. Microbios 82, 141-7.
8. Cipriani, P., Debbia, E. A., Gesu, G. P., Menozzi, M. G., Nani, E., Nicolosi, V. et al. (1995). Indagine policentrica AMCLI sull'incidenza di resistenze agli antibiotici in S. pyogenes. Microbiologia Medica 10, 171-4.
9. Cristiano, L., Bonzi, D., Noris, C., Valota, V., Quaini, M. & Marzulli, G. (1996). Streptococchi beta-emolitici di gruppo A: rapido incremento di ceppi resistenti all'eritromicina in un'area del nord Italia. Microbiologia Medica 11, 30-3.
10. Nakae, M., Murai, T., Kaneko, Y. & Mitsuhashi, S. (1977). Drug resistance in Streptococcus pyogenes isolated in Japan. Antimicrobial Agents and Chemotherapy 12, 427-8.
11. Seppälä, H., Klaukka, T., Lehtonen, R., Nenonen, E., Finnish Study Group for Antimicrobial Resistance & Huovinen, P. (1995). Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clinical Infectious Diseases 21, 1378-85.
12. Hsueh, P. R., Chen, H. M., Huang, A. H. & Wu, J. J. (1995). Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrobial Agents and Chemotherapy 39, 2239-42.
13. Bass, J. W., Weisse, M. E., Plymyer, M. R., Murphy, S. & Eberly, B. J. (1994). Decline of erythromycin resistance of group A β-hemolitic streptococci in Japan. Archives of Pediatrics and Adolescent Medicine 148, 67-71.
14. Seppälä, H., Nissinen, A., Järvinen, H., Huovinen, S., Henriksson, T., Herva, E. et al. (1992). Resistance to erythromycin in group A streptococci. New England Journal of Medicine 326, 292-7.
15. Sanders, E., Foster, M. T. & Scott, D. (1968). Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. New England Journal of Medicine 278, 538-40.
16. Stingemore, N., Francis, G. R. J., Toohey, M. & McGechie, D. B. (1989). The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Medical Journal of Australia 150, 630-1.
17. Phillips, G., Parratt, D., Orange, G. V., Harper, I., McEwan, H. & Young, N. (1990). Erythromycin-resistant Streptococcus pyogenes. Journal of Antimicrobial Chemotherapy 25, 723-4.
18. Seppälä, H., Nissinen, A., Yu, Q. & Huovinen, P. (1993). Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. Journal of Antimicrobial Chemotherapy 32, 885-91.
19. Sutcliffe, J., Tait-Kamradt, A. & Wondrack, L. (1996). Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrobial Agents and Chemotherapy 40, 1817-24.
20. Leclercq, R. & Courvalin, P. (1991). Bacterial resistance to macrolide, lincosamide and streptogramin antibiotics by target modification. Antimicrobial Agents and Chemotherapy 35, 1267-72.
21. Lode, H., Boeckh, M. & Schaberg, T. (1993). Human pharmacokinetics of macrolide antibiotics. In Macrolides. Chemistry, Pharmacology and Clinical Uses (Bryskier, A. J., Butzler, J. P., Neu, H. C. & Tulkens, P. M., Eds), pp. 409-20. Arnette Blackwell, Paris.
22. Pichichero, M. E. (1990). Controversies in the treatment of streptococcal pharyngitis. American Family Physician 42, 1567-76.
23. Principi, N. (1995). Management issues in paediatric pharyngitis and otitis media. International Journal of Antimicrobial Agents 6, 65-79.
24. Klugman, K. P. (1990). Pneumococcal resistance to antibiotics. Clinical Microbiology Reviews 3, 171-96.
25. Pallares, R., Liñares, J., Vadillo, M., Cabellos, C., Manresa, F., Viladrich, P. F. et al. (1995). Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. New England Journal of Medicine 333, 474-80.
26. Horodniceanu, T., Bougueleret, L. & Delbos, F. (1980). Phenotypic aspects of resistance to macrolide and related antibiotics in β-haemolytic group A, B, C, and G streptococci. In Recent Developments in Laboratory Identification Techniques (Facklam, R., Laurell, G. & Lind, I., Eds), pp. 122-31. Excerpta Medica, Amsterdam.
27. Holmström, L., Nyman, B., Rosengren, M., Wallander, S. & Ripa, T. (1990). Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centres. Scandinavian Journal of Infectious Diseases 22, 179-85.
28. Bryskier, A. J., Butzler, J. P., Neu, H. C. & Tulkens, P. M. (Eds) (1993). Macrolides. Chemistry, Pharmacology and Clinical Uses, Arnette Blackwell, Paris.
29. Gialdroni-Grassi, G. (1993). Macrolides in dental infections. In Macrolides. Chemistry, Pharmacology and Clinical Uses (Bryskier, A. J., Butzler, J. P., Neu, H. C. & Tulkens, P. M., Eds), pp. 617-24. Arnette Blackwell, Paris.
30. Soll, A. H. (1996). Medical treatment of peptic ulcer disease. Journal of the American Medical Association 275, 622-9.
31. Chang, H. R. & Pechère, J. C. (1993). Macrolides in toxoplasmosis. In Macrolides. Chemistry, Pharmacology and Clinical Uses (Bryskier, A. J., Butzler, J. P., Neu, H. C., Tulkens, P. M., Eds), pp. 321-6. Arnette Blackwell, Paris.
32. Ostroff, S. M., Spiegel, R. A., Feinberg, J., Benson, C. A. & Horsburgh, C. R. (1995). Preventing disseminated Mycobacterium avium complex disease in patients infected with human immunodeficiency virus. Clinical Infectious Diseases 21, Suppl. 1, S72-6.
33. Bisno, A. L. (1995). Streptococcus pyogenes. In Principles and Practice of Infectious Diseases, 4th edn, Vol. 2 (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 1786-99. Churchill Living-stone, New York, NY.
34. National Committee for Clinical Laboratory Standards. (1995). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically - Third edition. Approved Standard M7-A3. NCCLS, Villanova, PA.